Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization
- 1 May 1994
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 61 (5), 880-885
- https://doi.org/10.1016/s0015-0282(16)56700-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Gonadotropin responsiveness to ultralow-dose leuprolide acetate administration in baboonsFertility and Sterility, 1993
- Establishment of an Assisted Reproduction Program in the Armed ForcesMilitary Medicine, 1993
- The poor-responder patient in an in vitro fertilization-embryo transfer programJournal of Assisted Reproduction and Genetics, 1993
- The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind studyFertility and Sterility, 1992
- A novel superovulation regimen: three-day gonadotropin-releasing hormone agonist with overlapping gonadotropinsFertility and Sterility, 1991
- The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilizationFertility and Sterility, 1991
- Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeysFertility and Sterility, 1991
- Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilizationFertility and Sterility, 1990
- High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilizationJournal of Assisted Reproduction and Genetics, 1989
- Oocyte Assessment and Biological PerformanceAnnals of the New York Academy of Sciences, 1988